Skip to main content
Premium Trial:

Request an Annual Quote

Rene Bernards, Claire Fraser, Richard Schifreen, Joseph Williams


Rene Bernards, chief scientific officer of Agendia, has won the Spinoza prize from the Dutch Organization for Scientific Research, Agendia said today.

Bernards also heads the division of molecular carcinogenesis at the Netherlands Cancer Institute.

Claire Fraser has received the 2005 Promega Biotechnology Research Award, the Institute for Genomic Research said this week.

She is the president and director, as well as a co-founder, of TIGR.

She holds a PhD in pharmacology from the State University of New York at Buffalo and a BS in biology from Rensselaer Polytechnic Institute in New York.

Mirus Bio said last week that it has named Richard Schifreen as the company's vice president of research products.

Schifreen joins Mirus from Promega, where he served as director of technology and business development. He is also a faculty member of the University of Wisconsin-Madison in the masters of science in biotechnology program.

Schifreen holds a PhD in analytical chemistry from the University of Georgia, said Mirus, and is a diplomat of the American Board for Clinical Chemistry.

Mirus also said last week that it has appointed Joseph Williams as vice president of finance and administration.

Williams was previously vice president of finance and administration at Reliant Technologies, a medical laser company. Prior to this, he was CFO for a number of venture-funded startups, Mirus said.

Williams is a CPA and holds a bachelor's degree in accounting from Southwest Texas State University, according to Mirus.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.